For in vitro laboratory research only. Not for human or veterinary consumption.
India Warehouse RIVAROXABAN — 20mg per tablet, 112-count pack. Direct oral anticoagulant for stroke prevention in AF, DVT/PE treatment and prevention, post-surgical thromboprophylaxis, and cardiovascular event reduction in CAD/PAD. Key warning: Spinal epidural hematoma risk with neuraxial anesthesia. Strong CYP3A4/P-gp inhibitors greatly increase exposure. Reduce dose/avoid in renal impairment. No antidote until andexanet alfa (expensive).
Direct oral anticoagulant for stroke prevention in AF, DVT/PE treatment and prevention, post-surgical thromboprophylaxis, and cardiovascular event reduction in CAD/PAD.
How it Works
Direct Factor Xa inhibitor — blocks final common pathway of coagulation. Predictable pharmacokinetics allow fixed dosing without monitoring.
Spinal epidural hematoma risk with neuraxial anesthesia. Strong CYP3A4/P-gp inhibitors greatly increase exposure. Reduce dose/avoid in renal impairment. No antidote until andexanet alfa (expensive). International shipping: 7–14 days
Research use only
This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.
